Cabergoline and Impaired work ability - a phase IV clinical study of FDA data

Summary:

Impaired work ability is reported as a side effect among people who take Cabergoline (cabergoline), especially for people who are female, 30-39 old, have been taking the drug for 5 - 10 years also take Metformin, and have Bipolar disorder.

The phase IV clinical study analyzes which people have Impaired work ability when taking Cabergoline. It is created by eHealthMe based on reports of 5,946 people who have side effects when taking Cabergoline from the FDA, and is updated regularly.

What is Cabergoline?

Cabergoline has active ingredients of cabergoline. It is often used in prolactinoma. eHealthMe is studying from 6,257 Cabergoline users. Check the latest studies of Cabergoline.

What is Impaired work ability?

Impaired work ability is found to be associated with 1,012 drugs and 1,137 conditions by eHealthMe. Check the latest studies of Impaired work ability.

On Jul, 12, 2026

5,946 people reported to have side effects when taking Cabergoline.
Among them, 11 people (0.18%) have Impaired work ability.

Could Cabergoline cause Impaired work ability?

Among these 11 people:

How long have people been on Cabergoline when they have Impaired work ability? *

What is the gender of people who have Impaired work ability when taking Cabergoline? *

female: 54.55 %
male: 45.45 %

What is the age of people who have Impaired work ability when taking Cabergoline? *

What are other drugs people take besides Cabergoline? *

Metformin: 5 people, 45.45%
Levitra: 3 people, 27.27%
Plavix: 3 people, 27.27%
Ambien: 3 people, 27.27%
Amoxicillin And Clavulanate Potassium: 3 people, 27.27%
Androgel: 3 people, 27.27%
Ativan: 3 people, 27.27%
Crestor: 3 people, 27.27%
Cymbalta: 3 people, 27.27%
Xanax: 3 people, 27.27%

What are other side effects people have besides Impaired work ability? *

Pain: 5 people, 45.45%
Emotional Distress: 5 people, 45.45%
Fatigue (feeling of tiredness): 4 people, 36.36%
Drowsiness: 4 people, 36.36%
Apathy: 4 people, 36.36%
Anger: 4 people, 36.36%
Depressed Mood: 4 people, 36.36%
Panic Disorder: 4 people, 36.36%
Hypoaesthesia (reduced sense of touch or sensation): 4 people, 36.36%
Libido Decreased (loss of interest in sex): 3 people, 27.27%

What are the existing conditions these people have? *

Bipolar Disorder (mood disorder): 4 people, 36.36%
Stress And Anxiety: 3 people, 27.27%
Major Depression (a mood state that goes well beyond temporarily feeling sad or blue. it is a serious medical illness that affects one's thoughts, feelings): 3 people, 27.27%
Insomnia (sleeplessness): 3 people, 27.27%
Diabetes: 2 people, 18.18%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 2 people, 18.18%
Asthma: 2 people, 18.18%
Bone Density Decreased: 2 people, 18.18%
Depression: 2 people, 18.18%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 18.18%

* Approximation only. Some reports may have incomplete information.

Do you take Cabergoline and have Impaired work ability?

- Check whether Impaired work ability is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Cabergoline:

Cabergoline (6,257 reports)

Browse all side effects of Cabergoline:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Impaired work ability:

Impaired work ability (1,012 drugs)

Browse all the conditions that are associated with Impaired work ability:

Impaired work ability (1,137 conditions)

Related publications that referenced our studies

Gürbüz F, Ya?c?-Küpeli B, K?r Y, Yüksel B, Zorludemir S, Gürbüz BB, Küpeli S, "The first report of cabergoline-induced immune hemolytic anemia in an adolescent with prolactinoma", Journal of Pediatric Endocrinology and Metabolism, 2014 Jan .
Harris YT, Harris AZ, "Cabergoline associated with first episode mania", Psychosomatics, 2012 Jan .
Gürbüz F, Ya?c?-Küpeli B, K?r Y, Yüksel B, Zorludemir S, Gürbüz BB, Küpeli S, "The first report of cabergoline-induced immune hemolytic anemia in an adolescent with prolactinoma", Journal of Pediatric Endocrinology and Metabolism, 2014 Jan .
Harris YT, Harris AZ, "Cabergoline associated with first episode mania", Psychosomatics, 2012 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on cabergoline (the active ingredients of Cabergoline) and Cabergoline (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.